Wcn24-762 updated results from the ruby-3 study of povetacicept, an enhanced dual baff/april antagonist, in autoantibody-associated glomerulonephritis
Kidney International Reports(2024)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined